Blueprint Medicines Corporation (LON:0HOJ)
London
· Delayed Price · Currency is GBP · Price in USD 128.11
-0.05 (-0.04%)
At close: Jun 18, 2025
Blueprint Medicines Market Cap
Blueprint Medicines has a market cap or net worth of 6.16 billion as of June 20, 2025. Its market cap has increased by 19.93% in one year.
Market Cap
6.16B
Enterprise Value
6.02B
Revenue
435.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
128.11
Market Cap Chart
Since April 30, 2015, Blueprint Medicines's market cap has increased from 317.21M to 6.16B, an increase of 1,840.70%. That is a compound annual growth rate of 33.96%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 163.56B |
| GSK plc | 58.70B |
| Haleon | 34.55B |
| Smith & Nephew | 9.34B |
| ConvaTec Group | 5.76B |
| Hikma Pharmaceuticals | 4.55B |
| HUTCHMED (China) | 2.06B |
| Indivior | 1.30B |